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Abstract
SARS- CoV-2 is a recently emerged coronavirus that binds angiotensin- converting enzyme 2 (ACE2) for cell entry via its 
receptor- binding domain (RBD) on a surface- expressed spike glycoprotein. Studies show that despite its similarities to severe 
acute respiratory syndrome (SARS) coronavirus, there are critical differences in key RBD residues when compared to SARS- 
CoV-2. Here we present a short in silico study, showing that SARS- like bat coronavirus Rs3367 shares a high conservation 
with SARS- CoV-2 in important RBD residues for ACE2 binding: SARS- CoV-2’s Phe486, Thr500, Asn501 and Tyr505; implicated 
in receptor- binding strength and host- range determination. These features were not shared with other studied bat coronavi-
ruses belonging to the betacoronavirus genus, including RaTG13, the closest reported bat coronavirus to SARS- CoV-2’s spike 
protein. Sequence and phylogeny analyses were followed by the computation of a reliable model of the RBD of SARS- like bat 
coronavirus Rs3367, which allowed structural insight of the conserved residues. Superimposition of this model on the SARS- 
CoV-2 ACE2- RBD complex revealed critical ACE2 contacts are also maintained. In addition, residue Asn488
Rs3367
 interacted with 
a previously defined pocket on ACE2 composed of Tyr41, Lys353 and Asp355. When compared to available SARS- CoV-2 crystal 
structure data, Asn501
SARS- CoV-2
 showed a different interaction with the ACE2 pocket. Taken together, this study offers molecular 
insights on RBD- receptor interactions with implications for vaccine design.
INTRODUCTION
Since the first reports of pneumonia- like symptoms in 
December 2019 in the province of Hubei, PR China, the 
causative agent of COVID-19 disease was identified as 
severe acute respiratory syndrome (SARS) coronavirus 2 
(SARS- CoV-2). The virus has rapidly spread worldwide, and 
has been declared a global health pandemic by the World 
Health Organization in March 2020 [1]. As of 8 August 2020, 
there have been 19 187 943 laboratory- confirmed cases of 
COVID-19 and 716 075 reported deaths [2]. However, many 
of its molecular mechanisms, although under rapid investiga-
tion, are yet to be elucidated.
SARS- CoV-2 is an enveloped, positive- sense RNA betac-
oronavirus, which belongs to the sarbecovirus subgenus. In 
order to gain cell entry, it requires a glycoprotein known as 
spike (S), which is expressed on its surface. The S protein 
is known to trigger host immune responses [3] and is the 
target of neutralizing antibodies[4, 5] and a focus of vaccine 
design.
S is a glycosylated homotrimer, composed of a large ectodo-
main, a single transmembrane anchor and a C- terminal intra-
cellular tail [3]. The ectodomain encompasses two subunits, 
known as S1 and S2. The S1 subunit is responsible for receptor 
binding, with its C- terminal domain being critical for this 
interaction [6], also known as the receptor- binding domain 
(RBD). This spike region has been defined as the most variable 
part of SARS- CoV-2’s genome [4]. To engage with the host- cell 
receptor, the S1 subunit undergoes a number of conforma-
tional changes, where solved ectodomain cryo- EM structures 
have shown SARS- CoV-2’s spike can adopt both ‘open’ and 
‘closed’ conformations [7, 8]. Upon receptor binding, the S1 
subunit dissociates, and the S2 subunit, which contains the 
membrane fusion machinery, is responsible for mediating this 
process, which leads to viral entry into host cells [3].
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SARS- CoV-2 shares many similarities with SARS- CoV 
[9], where they both use angiotensin- converting enzyme 
2 (ACE2) as a host- cell receptor [4] and share conserved 
glycosylated sites on the S protein [7]. Moreover, it has 
been shown that alike SARS- CoV, SARS- CoV-2’s spike is 
primed by host- cell protease TMPRSS2 [10]. Despite their 
high sequence identity [4], SARS- CoV-2’s RBD differs in key 
residues [11], a region which has been identified as critical 
for ACE2 engagement [12]. These residues in SARS- CoV-2 
correspond to Leu455, Phe486, Gln493, Asn501 and Tyr505, 
with four out of five residues differing between SARS- CoV 
and SARS- CoV-2 [4], thought to alter the binding affinity 
to ACE2 [13], with described binding affinities of SARS- 
CoV-2’s RBD to ACE2 being higher compared to that of 
SARS- CoV [8, 14].
Recent reports have shown evidence of cross- reactivity in 
antibodies that target the spike of SARS- CoV and SARS-
 CoV-2 [15, 16]. While other studies concluded that potent 
neutralizing antibodies of SARS- CoV such as m396 and 
CR3014, which target the ACE2- binding site did not bind 
SARS- CoV2, indicating the differences in the RBD can have 
an impact on antibody cross- reactivity [8, 17].
Pangolin CoV isolate MP789 is the closest reported coro-
navirus to SARS- CoV-2 in the RBD region [18], whereas 
bat CoV RaTG13 has the closest sequence to SARS- CoV-2 
at both genome and spike- protein level [4], with confirmed 
ACE2 as the cell receptor [19].
Many horseshoe bats belonging to the Rhinolophus family are 
hosts of SARS- like (SL) coronaviruses, and they have been 
investigated in the context of the respiratory disease that first 
emerged in 2002–2003 [20], with some strains known to use 
ACE2 for cell entry [21–23]. Given the divergence in the 
molecular and structural spike- ACE2 interactions between 
SARS- CoV-2 and SARS- CoV, and bats being proposed as the 
original source of the virus [4], we set out to investigate other 
SL bat coronaviruses that may display sequence similarities 
in this variable albeit important region.
Bat SL coronavirus Rs3367 was first identified in March 2012 
and isolated in Yunnan, PR China [22]. Its host is Rhinolophus 
sinicus, and when the Rs3367’s full genome was sequenced, it 
showed 99.9 % identity to WIV1 coronavirus, which has been 
shown to use ACE2 for cell entry [22]. Through a combina-
tion of sequence and structural modelling analyses, we show 
that this SARS- like bat CoV has a high conservation with 
SARS- CoV-2 in key ACE2- binding residues within the RBD 
region [12, 13], with four out of six amino acids conserved, 
in contrast with other studied coronaviruses, including bat 
CoV RaTG13, and other alpha- and beta- CoVs, that showed 
little conservation in these reported residues. Furthermore, 
we present in silico evidence for the maintenance of critical 
ACE2 contacts for viral cell entry, which have been involved 
in conferring spike- receptor- binding strength [24]. In addi-
tion, a key difference was identified in the interaction of 
Rs3367 and SARS- CoV-2 RBDs with a critical pocket on 
ACE2, a pocket previously defined as a hotspot for viral cell 
entry [25].
METHODS
Sequence alignment
Sequence alignments of full- length spike proteins and for 
phylogeny analysis were performed in Clustal Omega [26] 
version 1.2.1. Percentage identity values were calculated 
from alignment data. All sequences were obtained from the 
National Centre for Biotechnology Information (NCBI) data-
base [27], with recorded accession numbers in Tables 1 and 
S1 (available in the online version of this article).
Sequence alignments for structural analysis were performed 
in Jalview [28] using the T Coffee with defaults setting. The 
sequences of SARS- CoV Tor2 isolate (GenBank: JX163928.1) 
and SARS- like bat coronavirus Rs3367 (GenBank: 
KC881006.1) were aligned. This alignment was then used for 
model input in MODELLER [29].
Phylogenetic analysis
Model selection and evolutionary analysis were performed 
in mega X [30, 31]. Model selection was conducted using 
mega’s Find Best- Fit substitution model setting [30, 31]. 
A maximum- likelihood tree was assembled using 43 spike 
protein sequences of selected coronaviruses (Fig. S1, Table 
S1), using the Whelan and Goldman frequency model [32]. 
Statistical support for nodes was assessed using 500 boot-
strap replicates. Initial tree(s) for the heuristic search were 
obtained automatically by applying Neighbor- Join and BioNJ 
algorithms to a matrix of pairwise distances estimated using 
the JTT model, and then selecting the topology with superior 
log- likelihood value. A discrete Gamma distribution was 
Table 1. Percentage identity scores of full- length spike proteins of 
selected coronaviruses (CoVs) compared to that of SARS- CoV-2. 
Spike- protein sequences of HCoVs NL63 and OC43, MERS CoV, bat CoV 
RaTG13, SARS- CoV, SARS- CoV-2, SARS- like (SL) bat CoVs RsSHC014, 
Rs3367, ZC45 and bat CoVs Rm1 and Rp3 were aligned using Clustal 
Omega [26]. Percentage identity scores (%) were calculated from 
alignment data. Spike- protein sequences were retrieved from the NCBI 
[27] database, with used accession numbers shown
Spike protein Accession no. Percentage identity (%) 
to SARS- CoV-2
HCoV NL63 YP_003767.1 27.72
HCoV OC43 AAR01015.1 31.41
MERS CoV YP_009047204.1 31.96
SARS CoV Tor2 isolate YP_009825051.1 76.72
Bat SL CoV Rs3367 AGZ48818.1 77.70
Bat SL CoV RsSHC014 AGZ48806.1 77.94
Bat CoV RaTG13 QHR63300.2 97.56
Bat SL CoV ZC45 AVP78031.1 82.30
Bat SL CoV Rf4092 ATO98145.1 75.51
Bat SARS CoV Rm1 ABD75332.1 76.62
Bat SARS CoV Rp3 AAZ67052.1 77.10
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used to model evolutionary rate differences among sites [five 
categories (+G, parameter=0.8911)]. There were a total of 
1653 positions in the final dataset.
ModBase protein modelling
UCSF’s ModBase web server [33] was used to model the 
RBD structure of Rs3367 SARS- like bat coronavirus based 
on known structural PDB data. Server input included a 
Jalview [28] sequence alignment file in fasta format of full- 
length Rs3367 (GenBank: KC881006.1) and SARS- CoV-2 
(GenBank: MN908947.3) sequences. Model selection criteria 
was set to the best and longest scoring model and selected 
fold- assignment method was the Slow (Seq- Prf, PSI- Blast). 
The output was of two models, and the model with the highest 
sequence identity to the input sequence was chosen, with a 
value of 95 %. The structural data corresponding to the crystal 
structure of the spike- protein RBD from the 2002–2003 SARS 
coronavirus human strain was used as a template for the 
model [34] (PDB code 3D0G). Model quality criteria outputs 
classified the model as reliable [35, 36], with key parameters 
summarized in Table 2. The ModPipe version SVN.r1661 and 
MSALL method [35] was used for model creation.
Model building of RBD of SARS-CoV-2 
superimposed on Rs3367 SARS-like bat 
coronavirus RBD
The structure of the spike glycoprotein RBD of SARS-
 CoV-2 (PDB: 6LZG, chain B) [14] was superimposed on the 
computed model of Rs3367 SARS- like bat coronavirus RBD 
in Chimera [37] using MatchMaker [38] structural- alignment 
command tool.
RESULTS
SARS-like bat coronavirus Rs3367 shares 
conserved structural features in the spike 
glycoprotein RBD
A multiple sequence alignment analysis of spike- protein 
sequences of selected alpha- and betacoronaviruses was 
conducted, focusing on the RBD region, which contains 
residues denoted as critical for human ACE2 receptor binding 
[12, 13]. The six residues correspond to Leu455, Phe486, 
Asn493, Thr500, Asn501 and Tyr505 in SARS- CoV-2. MERS-
 CoV and human coronavirus (HCoV) OC43 did not show 
any conservation in these residues, an expected result given 
both viruses are known to use a different receptor for cell 
entry [39, 40]. HCoV NL63, is able to use ACE2 for entry [41]. 
However, this alphacoronavirus did not have any conserved 
residues (Fig. 1).
Compared to SARS- CoV-2, the highest sequence identity of 
the spike- protein region corresponded to bat CoV RaTG13, 
with a value of 97.56 %, followed by SL bat CoVs ZC45, 
RsSHC014 and Rs3367, with corresponding identities of 82.30, 
77.94 and 77.70 %; with the last two being slightly higher than 
in SARS- CoV, as previously reported [22] (Table 1). When 
investigating ACE2- binding residue conservation, Rs3367 
had the most conserved residues compared to SARS- CoV-2, 
with four out of six conserved residues, as opposed to two 
in RaTG13 and one in ZC45 and RsSHC014 CoVs (Fig. 1). 
Table 2. SARS- like bat coronavirus Rs3367 spike- protein RBD model 
output parameters. The spike- protein RBD was modelled using 
MODELLER [29], using known structural data [34] (PDB code 3D0G) 
as the template. Output parameters and model characteristics are 
summarized below
Sequence identity 95 %
Protein length 243
Template PDB code 3D0G
Template region 349–502
E- value 0
GA341 1
MPQS* 1.64604
z- DOPE −0.09
Predicted RMSD (Å) 2.107
Predicted native overlap (3.5 Å) 0.969
*MPQS, ModPipe protein quality Score [35, 36].
Fig. 1. Sequence alignment of spike- protein region of HCoVs NL63 (541–595) and OC43 (462–519), MERS CoV (492–562), bat CoV RaTG13 
(453–506), SARS- CoV-2 (453–506), SARS- CoV Tor2 isolate (440–492), SARS- like bat CoVs RsSHC014 (441–493), Rs3367 (441–493), ZC45 
(444–483), Rf4092 (432–471), and bat SARS CoVs Rm1 (439–478) and Rp3 (439–478). A multiple sequence alignment was conducted in 
Clustal Omega [26]. Key residues critical for ACE2 binding [12, 13] are highlighted according to Clustal colouring. See Table 1 for selected 
accession numbers.
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Fig. 2. Phylogenetic tree based on the spike- protein sequences of CoVs and SARS- like CoVs. A maximum- likelihood tree was assembled 
in mega X [30, 31] using 43 spike- protein sequences of selected coronaviruses (Fig. S1,Table S1). The tree was inferred using the 
maximum- likelihood and Whelan and Goldman frequency model [32], with a discrete Gamma distribution to model evolutionary rate 
differences among sites [five categories (+G, parameter=0.8911)]. The tree with the highest log likelihood (−41046.54) is shown. The 
percentage of trees in which the associated taxa clustered together is shown next to the branches. The tree is drawn to scale, with 
branch lengths measured in the number of substitutions per site. Corresponding taxa names are indicated, with bat SARS- like CoV 
Rs3367 highlighted in bold and laboratory- confirmed ACE2- binding viruses indicated with cyan- coloured circles.
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SARS- like bat coronavirus Rs3367’s conserved RBD residues 
are Phe473, Thr487, Asn488 and Tyr492, which correspond to 
Phe486, Thr500, Asn501 and Tyr505 in SARS- CoV-2.
To place SARS- like bat CoV Rs3367 in an evolutionary 
context, we conducted a phylogenetic analysis focusing on 
the spike protein, including coronaviruses that both use and 
do not use ACE2 for cell entry (Fig. 2). Rs3367 clustered with 
other betacoronaviruses in the sarbecovirus subgenus, where 
SARS- CoV-2 and SARS- CoV also belong. Within the sarbeco-
virus branch, a highly supported node englobed bat SARS- like 
CoVs ZC45 and ZXC21, forming a distinct subclade from that 
containing pangolin CoV MP789, which branched off earlier 
than the subclade composed of SARS- CoV-2 and RaTG13, of 
98 % statistical support (Fig. 2).
In line with previous reports[22], Rs3367’s spike sequence 
was closest to bat CoV WIV1 and bat SL CoV Rs4084, both 
known to use ACE2 [22, 42]. It also clustered with other 
bat SL CoVs that have been confirmed for ACE2 receptor 
usage, which included SARS- CoV but not SARS- CoV-2 
(Fig. 2). Interestingly, Rs3367 did not cluster with another 
clade of SARS and SARS- like bat CoVs, which contained 
isolates that were reported as being incapable of ACE2 
binding, such as bat SL CoV As6526 [23] and bat SARS 
CoV Rp3 [43].
Due to the observed high degree of conservation in the 
reported ACE2- binding residues between SARS- CoV-2 
and bat SL CoV Rs3367, we investigated whether the global 
structural features of the spike’s RBD of this coronavirus 
also showed a conserved conformation when compared to 
SARS- CoV-2. Using a sequence alignment of SARS- like CoV 
Rs3367 and SARS- CoV as input, a structural model of the 
spike- protein RBD of this SARS- like bat strain was computed 
using ModBase web server [33], with known SARS- CoV 
structural data used as the template for modelling [34] (PDB: 
3D0G). Output parameters classified the model as reliable [35, 
36] (Table 2, Fig. 3).
The key conserved residues were observed and highlighted 
accordingly using Chimera [37], and the spike glycoprotein 
structure of SARS- CoV-2 [14] was superimposed on the 
modelled spike region from SARS- like CoV Rs3367 (Fig. 3). 
Modelling results revealed both RBD structures of the spikes 
have very similar three- dimensional structures, and indicate 
a conserved spatial conformation of SARS- CoV-2’s corre-
sponding Phe486, Asn501 and Tyr505 residues.
The two other critical residues which are not conserved 
between SARS- CoV-2 and Rs3367 correspond to Gln493SARS-
 CoV-2, with an asparagine in Rs3367 (Asn480Rs3367) and residue 
Leu455SARS- CoV-2, with a serine present instead (Ser443Rs3367) 
(Fig. 3). The Gln- Asn change concerns two amino acids that 
both have polar uncharged side chains, whereas the Leu- Ser 
change involves a neutral non- polar amino acid changing to 
a neutral polar amino acid, pointing to a more significant 
residue difference. However, the contributions of these 
changes to spike- ACE2 interactions are yet to be investigated.
Conserved ACE2-RBD interactions in SARS-CoV-2 
and SARS-like Rs3367 CoV
We then investigated whether the high degree of conservation 
in the spike RBD between SARS- like bat CoV Rs3367 and 
SARS- CoV-2 translated to conserved ACE2- spike contacts. 
To test this, the modelled RBD of Rs3367 was superimposed 
on the solved structure of ACE2 complexed with SARS-
 CoV-2 RBD [14]. This analysis revealed that not only are there 
key residues conserved, but it suggests, that ACE2 residues 
Met82, Gln42 and Lys353 interactions with Phe486, Thr500 
and Asn501 [13] are conserved in Rs3367, corresponding to 
Phe473, Thr487 and Asn488 (Fig. 4). To gain further detail 
on the receptor surface- RBD interactions between the spike 
proteins of Rs3367 and SARS- CoV-2, the solved structure 
of ACE2 complexed with SARS- CoV-2’s RBD (PDB: 6LZG) 
[14] was superimposed on the Rs3367 computed model 
in Chimera [37]. The Rs3367 model and ACE2 were then 
selected to be visualized alone (Fig. 5a).
This confirmed the conservation of two points of interaction 
of Rs3367 with ACE2 receptor, which have also been observed 
in SARS- CoV-2, corresponding to the atomic interactions 
of the spike RBD with Met82ACE2 near the N- terminus and 
with residues Gln42ACE2 and Lys353ACE2 farther away from the 
amino terminus.
Observing the surface- receptor conformation, two major 
pockets can be observed at those same locations (Fig. 5a). 
The pocket farther away from the N- terminus, which appears 
less exposed was further studied, given the involvement of 
two ACE2- RBD residue interactions instead of a single 
residue as in the case of Met82ACE2. In silico results showed 
the tyrosine- ACE2 pocket interactions, which take place in 
SARS- CoV-2 are conserved in Rs3367 (Fig. 5b, top panel), 
while in SARS- CoV-2 (Fig. 5b, bottom panel) Tyr505 residue 
conformation suggests a deeper interaction with the pocket, 
although structural refinement with additional data should 
confirm this.
Fig. 3. SARS- CoV-2 and SARS- like bat coronavirus Rs3367 spike- 
protein RBDs share key structural features. SARS- CoV-2 RBD (PDB 
6LZG, chain B) [14] was superimposed on the computed RBD model for 
Rs3367 SARS- like bat coronavirus using the mmaker [38] structural 
alignment command in Chimera [37]. Key residues involved in ACE2 
binding are highlighted in neon green (Rs3367) and purple (SARS- 
CoV-2).
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Furthermore, residue Asn488Rs3367, which corresponds to 
Asn501SARS- CoV-2, interacts with a pocket composed of the 
previously reported Lys353 [13] and residues Asp355 and 
Tyr41 (pocket shown in Fig. 5b). Although structural data has 
confirmed SARS- CoV-2’s Asn501 residue forms a hydrogen 
bond with ACE2’s Tyr41 [44], we found that, compared 
to Asn488Rs3367, SARS- CoV-2’s asparagine residue points 
outward and does not accommodate as well into the Tyr41- 
Lys353- Asp355 pocket compared to Rs3367’s interaction with 
the receptor surface (Fig. 5b). This difference may result in a 
change in ACE2- binding strength between the two viruses, 
however, its significance and whether this should prove 
advantageous for cell entry is yet to be ascertained.
DISCUSSION
To date, the closest identified coronavirus to SARS- CoV-2 
with bat origin is RaTG13 CoV, which shares a 96 % identity at 
whole- genome- sequence level and more than 93.1 % identity 
in the spike glycoprotein region [4]. Alongside other reported 
coronaviruses of the sarbecovirus subgenus such as SARS-
 CoV and SL CoV RsSHC014, RaTG13 has been shown to 
use receptor ACE2 for entry [19]. Despite its high sequence 
identity to SARS- CoV-2, RaTG13 and other studied CoVs 
showed little conservation in key ACE2- binding reported 
residues within the spike- protein RBD.
Although SARS- like bat coronavirus Rs3367 has a 77.70 % 
identity to SARS- CoV-2 in the spike sequence, it showed a 
high conservation in the studied ACE2- binding residues. This 
bat coronavirus shares a 99.9 % sequence identity with bat 
coronavirus WIV1, which was confirmed to use human, bat 
and civet ACE2 for cell entry [22]. Phylogeny spike- protein 
analysis revealed this strain clustered closely with other 
ACE2- using bat SL CoVs, where many shared the bat host 
Rhinolophus sinicus (Fig. 2).
Here, we reported using sequence data and through spike 
RBD structural modelling, a previously identified SARS- like 
bat coronavirus [22], which shares conserved structural 
features with SARS- CoV-2 in critical residues known from 
SARS- CoV studies to mediate ACE2- spike binding interac-
tions [13, 14].
A study looking at SARS- CoV-2’s RBD concluded its interac-
tions with ACE2 are stronger than those between SARS- CoV 
and ACE2 [45], where researchers defined Phe486 as a key 
residue, which has the ability to reach into a deep hydrophobic 
pocket in ACE2, and has a major role in conferring binding 
strength to this receptor [45]. Here we have shown that not 
only is this key residue conserved in Rs3367 at a sequence 
level, but its three- dimensional conformation also points to 
a conservation in its interaction with Met82ACE2, alongside 
conserved interactions with other key ACE2 residues, which 
include Gln42 and Lys353 as shown by the in silico structural 
studies of superimposing the RBDs of Rs3367 and SARS-
 CoV-2 (Fig. 4).
Surface ACE2 analyses with the RBDs of SARS- CoV-2 and 
Rs3367 have shown another pocket composed of Lys353, 
Asp355 and Tyr41 is important in the receptor- binding 
interactions of both Rs3367 and SARS- CoV-2, views which 
have been confirmed in SARS- CoV-2 by x- ray crystallog-
raphy data [44]. We found that SARS- like bat CoV Rs3367 
has an interaction with a critical ACE2 pocket, which differs 
from that of SARS- CoV-2 (Fig. 5b). This pocket has been 
previously defined as a viral hotspot for ACE2 interaction, 
Fig. 4. Conserved ACE2 and spike- protein RBD interactions in SARS- 
CoV-2 and SARS- like bat CoV Rs3367. The Rs3367 RBD model was 
superimposed on the structure of ACE2 receptor complexed with 
SARS- CoV-2 (PDB 6LZG) [14] in Chimera [37]. Conserved RBD residues 
are shown in neon green (Rs3367) and purple (SARS- CoV-2). ACE2 
residues are shown in cyan.
Fig. 5. Predicted SARS- like bat CoV Rs3367 interactions with ACE2 
receptor. (a) The surface structure of ACE2 (shown in cyan; PDB code: 
6LZG, chain A) [14] complexed with the RBD model of SARS- like bat 
Rs3367 coronavirus (salmon) viewed in Chimera [37], with key contact 
areas shown with black circles. (b) ACE2 surface- RBD interactions 
of conserved Y505
SARS-
 CoV-2 and N501
SARS- CoV-2
 residues in SARS- like 
Rs3367 coronavirus isolate (top panel; shown in neon green) and in 
SARS- CoV-2 (bottom panel; shown in purple). White residues in the top 
panel represent the composition of the ACE2 pocket [24] interacting 
with N488.
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where a study conducted in 2011 concluded its structure 
confers important energy contributions to ACE2- viral RBD 
interactions in SARS- CoV and NL63- CoV [46]. Tyr41 corre-
sponds to a histidine residue (His41) in the ACE2 receptor 
of several studied bat species [47], and has been proposed to 
be responsible for the weak binding of human SARS- CoV, 
where mutation of this residue to a tyrosine greatly increases 
receptor activity [47], implicating this pocket in human infec-
tivity. Furthermore, when Asn501SARS- CoV-2 was mutated to a 
threonine, this significantly reduced ACE2- binding affinity 
[19], indicating the importance of this residue in receptor 
binding. This residue is also conserved in SL bat CoV Rs3367 
and together with the presented in silico data, feature impor-
tant ACE2- RBD interactions, which may have implications 
in the context of vaccine design.
Study limitations
It is important to note that there are limitations to the Match-
Maker [38] alignment command used to superimpose and 
compare RBDs from SARS- CoV-2 and Rs3367 strains. The 
in silico data shown, although computed behind a reliable 
model (Table 2), is a representation of the plausible struc-
tural conformations that can ensue. Future biochemical data 
will allow gaining further insight into the nature of these 
molecular interactions between ACE2 and the spike viral 
protein of Rs3367.
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